ClinicalTrials.Veeva

Menu

Efficacy of Induction of Labor on Term Using a Double Balloon Catheter Compared to Dinoprostone Vaginal-insert

M

Medical University of Graz

Status and phase

Unknown
Phase 4

Conditions

Cervical Ripening
Induction of Labor

Treatments

Device: Cervical Ripening Balloon, Cook Medical Inc.
Drug: Dinoprostone

Study type

Interventional

Funder types

Other

Identifiers

NCT01720394
MUG-CRB-2012

Details and patient eligibility

About

The purpose of the study is to determine the efficacy of a silicone-double-balloon-catheter for cervical ripening and labor induction in women with unfavorable cervix (Bishop Score not greater than 6) compared to medical treatment using a dinoprostone slow-release-vaginal-insert.

Enrollment

253 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • medical indication for induction of labor
  • 18 years of age
  • signed informed consent
  • cephalic presentation
  • no PROM
  • 37+0 - 42+0 weeks of gestation
  • Bishop-Score ≤ 6
  • no contra-indication for medical induction of labor
  • no clinical signs of infection

Exclusion criteria

  • fetal anomalies
  • contra-indications for medical induction of labor
  • placental pathologies
  • St.p. surgery with opening the uterine cavity (incl. caesarean section)
  • PROM
  • multiple gestations
  • < 37-0 weeks of gestation
  • St.p. cervical tear

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

253 participants in 2 patient groups

Cervical ripening balloon
Experimental group
Description:
primary treatment with the cervical ripening balloon on day 1. removal of the balloon latest after 12 h. If no progression of labor (Bishop Score ≥ 9 and/or cervical opening ≥ 3 cm) continuing of standard treatment using dinoprostone vaginal-inserts on day 2 and if necessary on day 3.
Treatment:
Device: Cervical Ripening Balloon, Cook Medical Inc.
Propess
Active Comparator group
Description:
Primary treatment using dinoprostone-vaginal-inserts on day 1-3 if no progression of labor (Bishop Score ≥ 9 and/or cervical dilatation ≥ 3 cm)
Treatment:
Drug: Dinoprostone

Trial contacts and locations

7

Loading...

Central trial contact

Philipp Reif, MD; Philipp Klaritsch, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems